Correction to: Cardiotoxicity of Systemic Melanoma Treatments.

Curr Treat Options Oncol

Cardio-Oncology Center of Excellence, Division of Cardiovascular Medicine, Perelman School of Medicine at the University of Pennsylvania, 3400 Civic Center Blvd, Philadelphia, PA, 19104, USA.

Published: August 2022

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-022-00992-yDOI Listing

Publication Analysis

Top Keywords

correction cardiotoxicity
4
cardiotoxicity systemic
4
systemic melanoma
4
melanoma treatments
4
correction
1
systemic
1
melanoma
1
treatments
1

Similar Publications

Background: Second-generation antipsychotic medications (SGAs) are often used by primary care physicians (PCPs) to treat multiple psychiatric diagnoses. SGAs have been connected to a number of adverse effects, including cardiovascular disease. Currently, there are no published evidence-based recommendations addressing SGAs and cardiotoxicity that are directed toward PCPs.

View Article and Find Full Text PDF

Background And Objectives: Anthracycline chemotherapy is a cornerstone in pediatric oncology but carries a significant risk of cardiotoxicity. The early detection of cardiac dysfunction is crucial for timely intervention. This study aims to evaluate the predictive value of combining speckle tracking echocardiography (STE) parameters with traditional cardiac biomarkers for the early detection of anthracycline-induced cardiotoxicity in pediatric oncology patients.

View Article and Find Full Text PDF

Correction to: Sacubitril/valsartan attenuated myocardial inflammation, fibrosis, apoptosis and promoted autophagy in doxorubicin-induced cardiotoxicity mice via regulating the AMPKα-mTORC1 signaling pathway.

Mol Cell Biochem

November 2024

Department of Cardiology, Fujian Medical University Union Hospital, Fujian Cardiovascular Medical Center, Fujian Institute of Coronary Artery Disease, Fujian Cardiovascular Research Center, Fuzhou, 350001, People's Republic of China.

View Article and Find Full Text PDF
Article Synopsis
  • A study was conducted to compare the effects of hyperbaric levobupivacaine versus hyperbaric bupivacaine, both with fentanyl, in women undergoing elective cesarean sections.
  • A total of 130 women participated, with findings showing that levobupivacaine resulted in fewer side effects and shorter sensory and motor block durations than bupivacaine.
  • Both anesthetics maintained hemodynamic stability, but levobupivacaine provided effective pain relief for a shorter time, suggesting it as a viable option for cesarean procedures.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!